| Risk | High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.23% |
| NAV | ₹161.4 (18-Apr-2019) |
|---|---|
| Fund Started | 01-Jan-2013 |
| Fund Size | ₹2,664 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 11.9% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 11.0% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 9.6% |
| Cipla Ltd. | Healthcare | Equity | 9.3% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 7.2% |
| Syngene International Ltd. | Healthcare | Equity | 6.9% |
| Biocon Ltd. | Healthcare | Equity | 6.1% |
| Sanofi India Ltd. | Healthcare | Equity | 6.1% |
| Lupin Ltd. | Healthcare | Equity | 5.8% |
| Abbott India Ltd. | Healthcare | Equity | 4.8% |
Reliance Mutual Fund started their mutual fund on 30/06/1995 and its managing total assets of ₹2,32,169 Cr. Its ranked at 3 as per total assets at end of 30th Sep 2017.
Reliance Mutual Fund is a part of Reliance Anil Dhirubhai Ambani (ADA) Group and it is one of the largest growing asset management companies in India. It has an asset under management of Rs 239,145.
Reliance Mutual Fund is present across 160 cities across the country. The main motto of the asset management company is to launch products that are not only innovative, but also conducive for investors. They believe in increasing their value to investors.
RMF provides a host of mutual funds across various categories, be it equity, debt and hybrid. The schemes have a well-managed portfolio and it has pioneered to become one of the most trusted asset management companies in India.
Reliance Mutual Fund has been sponsored by Reliance Capital Limited and Nippon Life Insurance Company.